PSA Screening for HIM Act
Latest Action
Committee on Health, Education, Labor, and Pensions. Hearings held.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The PSA Screening for HIM Act (S.297) is a bill introduced in the 119th Congress, currently under consideration in the Senate. As of the latest update, the bill has been referred to the Committee on Health, Education, Labor, and Pensions, where hearings have been held. The bill's title suggests it relates to prostate-specific antigen (PSA) screening, potentially addressing health screening protocols for men, but no official summary or full text is publicly available to provide detailed provisions or objectives.
S.297 is a Senate bill focused on PSA screening, currently in committee with limited publicly available information on its specific content or policy impact.
- The bill is titled 'PSA Screening for HIM Act,' indicating a focus on PSA screening, likely related to men's health.
- It is currently in the Senate and has undergone committee hearings in the Health, Education, Labor, and Pensions Committee.
- No official summary or full text is available, limiting detailed analysis of its provisions or intended effects.
['Men who may be subject to PSA screening', 'Healthcare providers involved in PSA screening', 'Public health agencies overseeing screening programs']
['Lack of publicly available full text and summary limits understanding of implementation requirements or costs.', 'Unclear authority or oversight mechanisms due to missing detailed provisions.', 'Potential policy tradeoffs related to screening guidelines, healthcare resource allocation, or insurance coverage cannot be assessed.']
The bill is part of the 119th Congress legislative activity and is currently under committee review in the Senate. The focus on PSA screening aligns with ongoing public health discussions about cancer screening protocols. No further legislative history or bipartisan support information is available.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential changes in PSA screening practices could affect healthcare provider protocols and patient outcomes.', 'Adjustments in public health screening recommendations might influence insurance coverage and healthcare costs.', 'Committee hearings may lead to amendments that alter the scope or implementation of PSA screening policies.']
Transparency is limited due to the absence of the bill's full text and official summary, which constrains public and expert evaluation. Monitoring the committee's proceedings and any forthcoming text releases will be essential for thorough oversight and understanding of the bill's implications.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.